文献速递肿瘤 PET/CT

18F-FDG与68Ga-FAPI PET/CT显像原发性肝MALT淋巴瘤一例

18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
PubMed 文献 · Clin Nucl Med · 2022-01-01

本文报道一例76岁男性病理确诊的原发性肝结外边缘区黏膜相关淋巴组织(MALT)淋巴瘤,比较18F-FDG与68Ga-FAPI PET/CT表现。68Ga-FAPI PET/CT因肝实质摄取低,在肝病灶的靶/本底比优于18F-FDG PET/CT。提示68Ga-FAPI PET/CT或可作为评估淋巴瘤肝脏受累的替代方法,尤其对非FDG高摄取淋巴瘤。

要点

  • 原发性肝MALT淋巴瘤极罕见,本病例经病理确诊。
  • 68Ga-FAPI PET/CT在肝病灶的靶/本底比优于18F-FDG PET/CT。
  • 68Ga-FAPI PET/CT或可替代评估非FDG高摄取淋巴瘤的肝脏受累。

核心结论

  • 68Ga-FAPI PET/CT因肝实质摄取低,在肝病灶靶/本底比优于18F-FDG PET/CT。
  • 68Ga-FAPI PET/CT或可作为评估淋巴瘤肝脏受累的替代方法,尤其对非FDG高摄取淋巴瘤。

研究设计与样本

  • 个案报道,对象为一名76岁男性,病理确诊原发性肝结外边缘区黏膜相关淋巴组织(MALT)淋巴瘤。

主要发现

  • 68Ga-FAPI PET/CT在肝病灶的靶/本底比优于18F-FDG PET/CT。
  • 原因为肝实质对68Ga-FAPI摄取低。

临床怎么用

  • 对疑似原发性肝MALT淋巴瘤等非FDG高摄取淋巴瘤,可考虑68Ga-FAPI PET/CT评估肝脏受累。

局限性

  • 为单例个案报道,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of primary hepatic mucosa-associated lymphoid tissue lymphomas is extremely low. In this case, we present 18F-FDG and 68Ga-FAPI PET/CT findings in a 76-year-old man with pathologically confirmed primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. 68Ga-FAPI PET/CT showed a better tumor-to-background ratio than 18F-FDG PET/CT in the hepatic lesion because there is little 68Ga-FAPI uptake in the liver parenchyma. This case indicates that 68Ga-FAPI PET/CT may be an alternate method for evaluating hepatic involvement of lymphoma, especially for the non-FDG-avid lymphomas.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Pang Y, Zhao L, Shang Q, et al. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Clin Nucl Med. 2022. PMID: 34661557. doi:10.1097/RLU.0000000000003948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。